Latest filing published 27 May 2020 for Histogen Inc., €6,626.
Alfred P. Spada discloses dealings in Histogen Inc. to SEC (Form 4). In total, 3 filings cover trades dated from 27 February 2018 to 22 May 2020.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 27 May 2020: a share grant of €6,626, in Histogen Inc. Typically, a trade is published a median of 5 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations